0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

CLINICAL SYNTHESIS   |    
Supportive Oncology: New Models for the Role of Psychiatry in Cancer Care
Deane L. Wolcott, M.D.; Paul B. Jacobsen, Ph.D.; Matthew J. Loscalzo, M.S.W.
FOCUS 2013;11:471-481. doi:10.1176/appi.focus.11.4.471
View Author and Article Information

Author Information and CME Disclosure

Deane L. Wolcott, M.D., Director, Oncology Supportive Care Services, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Paul B. Jacobsen, Ph.D., Associate Center Director for Population Science at Moffitt and Professor of Psychology and Oncologic Sciences at the University of South Florida.

Matthew J. Loscalzo, MSW., Liliane Elkins Professor in Supportive Care Programs, Executive Director, Department of Supportive Care Medicine, and Professor, Department of Population Sciences, City of Hope, Duarte, CA.

Deane Wolcott and Matthew Loscalzo report no competing interests.

Paul Jacobsen reports Support Screen Royalties, Inventor of screening technology.

Address correspondence to Deane L. Wolcott, M.D., Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048 deane.wolcott@cshs.org

Abstract

The last 40 years have seen dramatic advances in the scientific understanding of the mechanisms underlying the clinical behavior of cancer and in the effectiveness of cancer prevention, diagnosis, staging, and treatments. Cancer care can now often be truly individualized, based on measurement of tumor biomarkers, advanced imaging technology, and use of targeted anticancer treatments. Treatment advances have resulted in the creation of large numbers of cancer survivors, and to the recognition that cancer is now often a chronic, rather than acutely life-threatening, illness. Evolution of our scientific and clinical understanding of the human dimensions of cancer and cancer care can be encapsulated in the progression of descriptive terms from psycho-oncology, to psychosocial oncology, to supportive oncology. Now a broad range of cancer patient and family services are recognized as being important to providing comprehensive patient-centered cancer care as one component of the patient’s overall care delivery experience. This paper reviews information on psychiatric aspects of cancer and cancer treatment, the role of psychiatry and behavioral health services, best practice organizational models for provision of integrated supportive oncology services within the hospital cancer program environment, and the increasing importance of supportive oncology national quality of care standards.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Figure 1. Supportive Oncology Services Model
Anchor for Jump
Table 1.Selected National Oncology Patient Information and Supportive Oncology Services Providers
+

References

Siegel  R;  Naishadham  D;  Jemal  A:  Cancer statistics, 2012.  CA Cancer J Clin 2012; 62:10–29
[CrossRef] | [PubMed]
 
Hopwood  P;  Watson  M:  Genetic susceptibility to breast/ovarian cancer, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 105–109
 
American Cancer Society: Cancer Treatment & Survivorship Facts and Figures: 2012-2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveillance/documents/document/aspc-033876.pdf. Accessed Sept 5, 2013
 
Weaver  KE;  Forsythe  LP;  Reeve  BB;  Alfano  CM;  Rodriguez  JL;  Sabatino  SA;  Hawkins  NA;  Rowland  JH:  Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey.  Cancer Epidemiol Biomarkers Prev 2012; 21:2108–2117
[CrossRef] | [PubMed]
 
Alfano  CM;  Ganz  PA;  Rowland  JH;  Hahn  EE:  Cancer survivorship and cancer rehabilitation: revitalizing the link.  J Clin Oncol 2012; 30:904–906
[CrossRef] | [PubMed]
 
Holland  JC;  Weiss  TR:  History of psycho-oncology, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 3–12
 
Golant  M;  Thiboldeaux  K:  The Wellness Community’s integrative model of evidence-based psychosocial programs, services, and interventions, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 473–478
 
Stanton AL, Thompson EH, Crespi CM, Link JS, Waisman JR: Project connect online: randomized trial of an internet-based program to chronicle the cancer experience and facilitate communication. J.Clin Oncol 2013; 31:1–109
 
Deshields  T;  Zebrack  B;  Kennedy  V;  Link  JS;  Waisman  JR:  The state of psychosocial services in cancer care in the United States.  Psychooncology 2013; 22:699–703
[CrossRef] | [PubMed]
 
Fann  JR;  Ell  K;  Sharpe  M:  Integrating psychosocial care into cancer services.  J Clin Oncol 2012; 30:1178–1186
[CrossRef] | [PubMed]
 
Boykoff  N;  Moieni  M;  Subramanian  SK:  Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response.  J Cancer Surviv 2009; 3:223–232
[CrossRef] | [PubMed]
 
Strada  ES;  Sourkes  BM:  Principles of Psychotherapy, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 397–401
 
Spira  JL;  Casden  DR:  Group Psychotherapy for persons with cancer, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 408–414
 
Massie  MJ;  Miller  K:  Oncology, in  The American Psychiatric Association Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill , 2nd ed. Edited by Levenson  JL.  Arlington, VA,  American Psychiatric Publishing, Inc, 2012, pp 525–549
 
Braun  IM;  Pirl  WF;  Greenberg  DB:  Patients with Cancer, in  The Massachusetts General Hospital Handbook of General Hospital Psychiatry , 6th ed. Edited by Stern  TA;  Fricchione  GL;  Cassem  NH;  Jellinek  MS;  Rosenbaum  JF.  Philadelphia, PA,  Saunders/Elsevier, 2010, pp 371–382
 
Breitbart  WS;  Alici  Y:  Delirium, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 332–339
 
Miller  K;  Massie  MJ:  Depressive Disorders, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 311–318
 
Strouse TB: Psychopharmacologic treatment of depression in patients with cancer: a 2013 update. Focus 2013; 11:450–459
 
Levin  TT;  Alici  Y:  Anxiety Disorders, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 324–331
 
Yue  HJ;  Dimsdale  JE:  Sleep and Cancer, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 258–269
 
Braun  IM;  Pirl  WF:  Psychotropic Medications in Cancer, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 378–385
 
Lash  TL;  Cronin-Fenton  D;  Ahern  TP;  Rosenberg  CL;  Lunetta  KL;  Silliman  RA;  Hamilton-Dutoit  S;  Garne  JP;  Ewertz  M;  Sørensen  HT;  Pedersen  L:  Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.  Acta Oncol 2010; 49:305–312
[CrossRef] | [PubMed]
 
Montgomery  SA:  Antidepressants and seizures: emphasis on newer agents and clinical implications.  Int J Clin Pract 2005; 59:1435–1440
[CrossRef] | [PubMed]
 
Turner  MS;  May  DB;  Arthur  RR;  Xiong  GL:  Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks.  J Intern Med 2007; 261:205–213
[CrossRef] | [PubMed]
 
Beach  SR;  Celano  CM;  Noseworthy  PA;  Januzzi  JL;  Huffman  JC:  QTc prolongation, torsades de pointes, and psychotropic medications.  Psychosomatics 2013; 54:1–13
[CrossRef] | [PubMed]
 
Henry  NL;  Stearns  V;  Flockhart  DA;  Hayes  DF;  Riba  M:  Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.  Am J Psychiatry 2008; 165:1251–1255
[CrossRef] | [PubMed]
 
Boyer  EW;  Shannon  M:  The serotonin syndrome.  N Engl J Med 2005; 352:1112–1120
[CrossRef] | [PubMed]
 
Dalmau  J;  Rosenfeld  MR:  Paraneoplastic syndromes of the CNS.  Lancet Neurol 2008; 7:327–340
[CrossRef] | [PubMed]
 
Wijdicks  EFT:  Neurotoxicity of immunosuppressive drugs.  Liver Transpl 2001; 7:937–942
[CrossRef] | [PubMed]
 
Schusse  CM;  Peterson  AL;  Caplan  JP:  Posterior reversible encephalopathy syndrome.  Psychosomatics 2013; 54:205–211
[CrossRef] | [PubMed]
 
Wolf  S;  Barton  D;  Kottschade  L;  Grothey  A;  Loprinzi  C:  Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.  Eur J Cancer 2008; 44:1507–1515
[CrossRef] | [PubMed]
 
Pain  C:  Assessment and Management , 2nd ed. Edited by Bruera  ED;  Portenoy  RK.  New York, NY,  Cambridge University Press, 2010
 
Breitbart  WS;  Park  J;  Katz  AM:  Pain, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 215–228
 
Weingart  SN;  Cleary  A;  Stuver  SO;  Lynch  M;  Brandoff  D;  Schaefer  KG;  Zhu  J;  Berry  DL;  Block  S;  Weeks  JC:  Assessing the quality of pain care in ambulatory patients with advanced stage cancer.  J Pain Symptom Manage 2012; 43:1072–1081
[CrossRef] | [PubMed]
 
Breitbart  WS;  Alici  Y:  Fatigue, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 236–244
 
Fleishman  SB;  Chadha  JS:  Weight and Appetite Loss in Cancer, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 270–274
 
Mortimer  JE:  Managing the toxicities of the aromatase inhibitors.  Curr Opin Obstet Gynecol 2010; 22:56–60
[CrossRef] | [PubMed]
 
Nelson  HD;  Vesco  KK;  Haney  E;  Fu  R;  Nedrow  A;  Miller  J;  Nicolaidis  C;  Walker  M;  Humphrey  L:  Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.  JAMA 2006; 295:2057–2071
[CrossRef] | [PubMed]
 
Ahles  TA;  Correa  DD:  Neuropsychological Impact of Cancer and Cancer Treatments, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 251–257
 
Ahles  TA:  Brain vulnerability to chemotherapy toxicities.  Psychooncology 2012; 21:1141–1148
[CrossRef] | [PubMed]
 
Asher  A:  Cognitive dysfunction among cancer survivors.  Am J Phys Med Rehabil 2011; 90(Suppl 1):S16–S26
[CrossRef] | [PubMed]
 
Strouse  TB;  Flanagan  F;  Kerrihard  T;  Williams  C;  Wolcott  DL:  Managing cancer pain in a 24-hour outpatient cancer center.  J Support Oncol 2006; 4:351–354 [Also at http://www.SupportiveOncology.net]
[PubMed]
 
Levit L, Balogh E, Nass S, Ganz PA (Eds): Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population; Board on Health Care Services, Institute of Medicine. (2013) Pre-publication. National Academies Press at http://www.nap.edu/catalog.php?record_id=18359. Accessed on Sept 10, 2013)
 
Breitbart  W;  Chochinov  HM;  Alici  Y:  Palliative Care, in  The American Psychiatric Association Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill , 2nd ed. Edited by Levenson  JL.  Arlington, VA,  American Psychiatric Publishing, Inc, 2012, pp 1053–1084
 
Brendel  RW;  Wei  M;  Epstein  LA;  Cassem  NH:  Care at the end of life, in  The Massachusetts General Hospital Handbook of General Hospital Psychiatry , 6th ed. Edited by Stern  TA;  Fricchione  GL;  Cassem  NH;  Jellinek  MS;  Rosenbaum  JF.  Philadelphia, PA,  Saunders/Elsevier, 2010, pp 555–563
 
Care P: Transforming the Care of Serious Illness. Edited by Meier DE, Isaacs SL, Hughes RG. San Francisco, CA, Jossey-Bass A Wiley Imprint, 2010. (Robert Wood Johnson Series on Health Policy)
 
Walsh  D;  Caraceni  AT;  Fainsinger  R;  Foley  K;  Glare  P;  Goh  C;  Lloyd-Williams  M;  Olarte  JN;  Radbruch  L (ed):  Palliative Medicine .  Philadelphia, PA,  Saunders an Imprint of Elsevier, Inc., 2009
 
Handbook of Psychiatry in Palliative Medicine, 2nd ed. Edited by Chochinov  HM;  Breitbart  W.  New York, NY,  Oxford University Press, 2009
 
Fairman N, Irwin SA: Palliative care psychiatry: Update on an emerging dimension of psychiatric practice. Curr Psychiatry Rep 2013;15 (Suppl):374 (1-9)
 
Burton  CZ;  Twamley  EW;  Lee  LC;  Palmer  BW;  Jeste  DV;  Dunn  LB;  Irwin  SA:  Undetected cognitive impairment and decision-making capacity in patients receiving hospice care.  Am J Geriatr Psychiatry 2012; 20:306–316
[CrossRef] | [PubMed]
 
Chochinov  HM:  Psychiatry and palliative care: 2 sides of the same coin.  Can J Psychiatry 2008; 53:711–712
[PubMed]
 
Rao  S;  Ferris  FD;  Irwin  SA:  Ease of screening for depression and delirium in patients enrolled in inpatient hospice care.  J Palliat Med 2011; 14:275–279
[CrossRef] | [PubMed]
 
Irwin  SA;  Rao  S;  Bower  K;  Palica  J;  Rao  SS;  Maglione  JE;  Soskins  M;  Betterton  AE;  Ferris  FD:  Psychiatric issues in palliative care: recognition of depression in patients enrolled in hospice care.  J Palliat Med 2008; 11:158–163
[CrossRef] | [PubMed]
 
Irwin  SA;  Ferris  FD:  The opportunity for psychiatry in palliative care.  Can J Psychiatry 2008; 53:713–724
[PubMed]
 
Puchalski  C;  Ferrell  B;  Virani  R;  Otis-Green  S;  Baird  P;  Bull  J;  Chochinov  H;  Handzo  G;  Nelson-Becker  H;  Prince-Paul  M;  Pugliese  K;  Sulmasy  D:  Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference.  J Palliat Med 2009; 12:885–904
[CrossRef] | [PubMed]
 
Smith  TJ;  Temin  S;  Alesi  ER;  Abernethy  AP;  Balboni  TA;  Basch  EM;  Ferrell  BR;  Loscalzo  M;  Meier  DE;  Paice  JA;  Peppercorn  JM;  Somerfield  M;  Stovall  E;  Von Roenn  JH:  American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care.  J Clin Oncol 2012; 30:880–887
[CrossRef] | [PubMed]
 
Glare  PA;  Semple  D;  Stabler  SM;  Saltz  LB:  Palliative care in the outpatient oncology setting: evaluation of a practical set of referral criteria.  J Oncol Pract 2011; 7:366–370
[CrossRef] | [PubMed]
 
Ferris  FD;  Bruera  E;  Cherny  N;  Cummings  C;  Currow  D;  Dudgeon  D;  Janjan  N;  Strasser  F;  von Gunten  CF;  Von Roenn  JH:  Palliative cancer care a decade later: accomplishments, the need, next steps — from the American Society of Clinical Oncology.  J Clin Oncol 2009; 27:3052–3058
[CrossRef] | [PubMed]
 
Kelley  AS;  Meier  DE:  Palliative care—a shifting paradigm.  N Engl J Med 2010; 363:781–782
[CrossRef] | [PubMed]
 
Teno  JM;  Gozalo  PL;  Bynum  JPW;  Leland  NE;  Miller  SC;  Morden  NE;  Scupp  T;  Goodman  DC;  Mor  V:  Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009.  JAMA 2013; 309:470–477
[CrossRef] | [PubMed]
 
Bruera  E;  Hui  D:  Conceptual models for integrating palliative care at cancer centers.  J Palliat Med 2012; 15:1261–1269
[CrossRef] | [PubMed]
 
Yennurajalingram  S;  Urbauer  DL;  Casper  KLB;  Reyes-Gibby  CC;  Chacko  R;  Poulter  V;  Bruera  E:  Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic.  J Pain Symptom Manage 2011; 41:49–56
[CrossRef]
 
Chochinov  HM;  Kristjanson  LJ;  Breitbart  W;  McClement  S;  Hack  TF;  Hassard  T;  Harlos  M:  Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial.  Lancet Oncol 2011; 12:753–762
[CrossRef] | [PubMed]
 
Chochinov  HM;  Hack  T;  Hassard  T;  Kristjanson  LJ;  McClement  S;  Harlos  M:  Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life.  J Clin Oncol 2005; 23:5520–5525
[CrossRef] | [PubMed]
 
Montross  L;  Winters  KD;  Irwin  SA:  Dignity therapy implementation in a community-based hospice setting.  J Palliat Med 2011; 14:729–734
[CrossRef] | [PubMed]
 
Breitbart  W;  Poppito  S;  Rosenfeld  B;  Vickers  AJ;  Li  Y;  Abbey  J;  Olden  M;  Pessin  H;  Lichtenthal  W;  Sjoberg  D;  Cassileth  BR:  Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer.  J Clin Oncol 2012; 30:1304–1309
[CrossRef] | [PubMed]
 
Temel  JS;  Greer  JA;  Muzikansky  A;  Gallagher  ER;  Admane  S;  Jackson  VA;  Dahlin  CM;  Blinderman  CD;  Jacobsen  J;  Pirl  WF;  Billings  JA;  Lynch  TJ:  Early palliative care for patients with metastatic non-small-cell lung cancer.  N Engl J Med 2010; 363:733–742
[CrossRef] | [PubMed]
 
Greer  JA;  Pirl  WF;  Jackson  VA;  Muzikansky  A;  Lennes  IT;  Heist  RS;  Gallagher  ER;  Temel  JS:  Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer.  J Clin Oncol 2012; 30:394–400
[CrossRef] | [PubMed]
 
Integrative Oncology. Edited by Abrams DI, Weil AT. New York, NY, Oxford University Press, Inc., 2009 (Weil Integrative Medicine Library)
 
Cohen  L;  Russell  N;  Garcia  MK;  Biegler  KA;  Frenkel  M:  Integrative Oncology, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 447–454
 
Wesa  K;  Gubili  J;  Cassileth  BR:  Integrative oncology: complementary therapies for cancer survivors.  Hematol Oncol Clin North Am 2008; 22:343–353, viii
[CrossRef] | [PubMed]
 
Cassileth  BR;  Vickers  AJ:  High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care.  J Clin Oncol 2005; 23:2590–2592
[CrossRef] | [PubMed]
 
Brandon  TH;  Unron  D:  Tobacco Use and Cessation, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 15–21
 
Demark-Wahnefried  W;  Pinto  BM;  Gritz  ER:  Promoting health and physical function among cancer survivors: potential for prevention and questions that remain.  J Clin Oncol 2006; 24:5125–5131
[CrossRef] | [PubMed]
 
Danovitch  I:  The clinical assessment and treatment of nicotine dependence.  Focus 2011; 9:15–24
 
Partridge  AH;  LaFountain  A;  Mayer  E;  Taylor  BS;  Winer  E;  Asnis-Alibozek  A:  Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.  J Clin Oncol 2008; 26:556–562
[CrossRef] | [PubMed]
 
Lin  JH;  Zhang  SM;  Manson  JE:  Predicting adherence to tamoxifen for breast cancer adjuvant therapy and prevention.  Cancer Prev Res (Phila) 2011; 4:1360–1365
[CrossRef] | [PubMed]
 
Lash  TL;  Fox  MP;  Westrup  JL;  Fink  AK;  Silliman  RA:  Adherence to tamoxifen over the five-year course.  Breast Cancer Res Treat 2006; 99:215–220
[CrossRef] | [PubMed]
 
Partridge  AH;  Avorn  J;  Wang  PS;  Winer  EP:  Adherence to therapy with oral antineoplastic agents.  J Natl Cancer Inst 2002; 94:652–661
[CrossRef] | [PubMed]
 
Shulman  LN;  Jacobs  LA;  Greenfield  S;  Jones  B;  McCabe  MS;  Syrjala  K;  Diller  L;  Shapiro  CL;  Marcus  AC;  Campbell  M;  Santacroce  S;  Kagawa-Singer  M;  Ganz  PA:  Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future? J Oncol Pract 2009; 5:119–123
[CrossRef] | [PubMed]
 
Ganz  PA;  Hahn  EE:  Implementing the Survivorship Care Plan: A Strategy for improving the quality of care of cancer patients, in  Psycho-Oncology , 2nd ed. Edited by Holland  JC;  Breitbart  WS;  Jacobsen  PB;  Lederberg  MS;  Loscalzo  MJ;  McCorkle  R.  New York, NY,  Oxford University Press, 2010, pp 557–561
 
Wise  TN;  Biondi  M;  Constantini  A (ed):  Psycho-Oncology .  Arlington, VA,  American Psychiatric Publishing, Inc., 2013
 
Loscalzo  MJ;  Von Gunten  C:  Interdisciplinary teamwork in palliative care: Compassionate expertise for serious illness, in  Handbook of Psychiatry in Palliative Medicine , 2nd ed. Edited by Chochinov  HM;  Breitbart  W.  New York, NY,  Oxford University Press, 2009, pp 172–185
 
Loscalzo MJ, Bultz BD, Jacobsen PB: Building psychosocial programs: a roadmap to excellence, in Psycho-Oncology, 2nd ed. Edited by Holland JC, Breitbart WS, Jacobsen PB, Lederberg MS, Loscalzo MJ, McCorkle R. New York, Oxford University Press, 2010:, pp 569–574
 
Loscalzo  M;  Clark  KL;  Holland  J:  Successful strategies for implementing biopsychosocial screening.  Psychooncology 2011; 20:455–462
[CrossRef] | [PubMed]
 
Bultz  BD;  Groff  SL;  Fitch  M;  Blais  MC;  Howes  J;  Levy  K;  Mayer  C:  Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice.  Psychooncology 2011; 20:463–469
[CrossRef] | [PubMed]
 
Mitchell  AJ:  Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol 2013; 52:216–224
[CrossRef] | [PubMed]
 
Clark  K;  Bardwell  WA;  Arsenault  T;  DeTeresa  R;  Loscalzo  M:  Implementing touch-screen technology to enhance recognition of distress.  Psychooncology 2009; 18:822–830
[CrossRef] | [PubMed]
 
Adler  NE;  Page  A:  Institute of Medicine, Committee on Psychosocial Services to Cancer Patients/Families in Cancer care for the Whole Patient: meeting psychosocial health needs .  Washington, D.C,  National Academies Press, 2008
 
Carlson  LE;  Waller  A;  Mitchell  AJ:  Screening for distress and unmet needs in patients with cancer: review and recommendations.  J Clin Oncol 2012; 30:1160–1177
[CrossRef] | [PubMed]
 
Sanson-Fisher  R;  Girgis  A;  Boyes  A;  Bonevski  B;  Burton  L;  Cook  P; Supportive Care Review Group:  The unmet supportive care needs of patients with cancer.  Cancer 2000; 88:226–237
[CrossRef] | [PubMed]
 
Kohn  LT;  Corrigan  JM;  Donaldson  MS (ed):  To Err Is Human: Building a Safer Health System .  Washington,  National Academies Press, 1999
 
Mitchell  AJ;  Kaar  S;  Coggan  C;  Herdman  J:  Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists.  Psychooncology 2008; 17:226–236
[CrossRef] | [PubMed]
 
Institute of Medicine:  Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs .  Washington,  National Academies Press, 2008
 
Commission on Cancer: Cancer program standards 2012: ensuring patient-centered care, http://facs.org/cancer/coc/programstandards2012.html, Accessed July 24, 2013
 
Oncology Nursing Society: Oncology Nursing Society issues joint position statement on implementing screening for distress, http://www.ons.org/news.aspx?id=285, Accessed July 24, 2013
 
Wagner  LI;  Spiegel  D;  Pearman  T:  Using the science of psychosocial care to implement the new american college of surgeons commission on cancer distress screening standard.  J Natl Compr Canc Netw 2013; 11:214–221
[PubMed]
 
National Comprehensive Cancer Network: NCCN guidelines for supportive care, http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#supportive, Accessed July 24, 2013
 
National Comprehensive Cancer Network:  NCCN practice guidelines for the management of psychosocial distress.  Oncology (Williston Park) 1999; 13(5A):113–147[Williston Park]
[PubMed]
 
National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology. Distress management. V2.2013, http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf. Accessed July 24, 2013
 
Li  M;  Fitzgerald  P;  Rodin  G:  Evidence-based treatment of depression in patients with cancer.  J Clin Oncol 2012; 30:1187–1196
[CrossRef] | [PubMed]
 
Institute of Medicine:  Clinical practice guidelines we can trust .  Washington,  National Academies Press, 2011
 
AGREE Collaboration:  Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project.  Qual Saf Health Care 2003; 12:18–23
[CrossRef] | [PubMed]
 
Children's Oncology Group: Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancer, http://www.survivorshipguidelines.org/, Accessed July 24, 2013
 
References Container
+
+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
Who coined the term “psychosomatic medicine?”

See Friedman and Muskin; Clinical Context, History, p 441
2.
Research demonstrates that concordance rates with consultation recommendations primarily depend upon which of the following factors?

See Friedman and Muskin; Treatment Strategies and Evidence, p 443
3.
In treating an agitated delirious patient with a pre-existing dementia in the ICU, which of the following factors influences the choice of an antipsychotic medication?

See Friedman and Muskin; Agitated Patient, p 445
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 21.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 21.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 24.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 7.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 20.  >
Topic Collections
Psychiatric News
PubMed Articles